Comparative studies of antibacterial activity in vitro and absorption and excretion of lincomycin and clinimycin.
about
A new strategy to fight antimicrobial resistance: the revival of old antibioticsTreatment of Bacteroides infection with clindamycin-2-phosphateThe pseudomembranous colitis associated with clindamycin therapy--a viral colitis.Clindamycin--efficacy and toxicity.Plasma, bone, hip capsule, synovial and drain fluid concentrations of lincomycin during total hip replacementPlasma, bone, hip capsule and drain fluid concentrations of ampicillin and flucloxacillin during total hip replacement after intravenous bolus injection of magnapenParenteral clindamycin phosphate: pharmacology with normal and abnormal liver function and effect on nasal staphylococciSusceptibility of beta-hemolytic streptococci to 65 antibacterial agents.Bone concentrations of antimicrobial agents after parenteral administrationIdentification of adverse reactions to new drugs. II (continued): How were 18 important adverse reactions discovered and with what delays?7-Chlorolincomycin therapy of pulmonary infections due to Myoplasma pneumoniae.Promotion of the translocation of enteric bacteria from the gastrointestinal tracts of mice by oral treatment with penicillin, clindamycin, or metronidazole.Clindamycin levels in sputum in a patient with purulent chest disease due to cystic fibrosis.Epidemiology of antimicrobial resistance in bloodstream infections.Therapy of staphylococcal infections in monkeys. VI. Comparison of clindamycin, erythromycin, and methicillin.Susceptibility of various serogroups of streptococci to clindamycin and lincomycin.Streptococcal pharyngitis therapy: comparison of clindamycin palmitate and potassium phenoxymethyl penicillin.Clinical uses and control of rifampicin and clindamycin.A method for studying antibiotic concentrations in inflammatory exudate.Membrane filtration in the study of antimicrobial drugsPediatric antimicrobial therapy 3.Pediatric antimicrobial therapy I.Plasma, bone, hip capsule, and drain fluid concentrations of cephazolin during total hip replacement.
P2860
Q21131083-6B661175-D23D-45DE-A1C7-2263F68AE29EQ28363600-E5C71973-1425-438A-92CA-352545031EB6Q30830205-E3F844FB-51A9-4BF6-995C-E72F4D79E03BQ33823463-0D4832F1-34EF-45F2-A9C1-1A58BB7C549BQ34515729-648367CA-7B9C-4188-966C-B9CC71D7F6FBQ34516758-09CB9DEB-C571-4DCB-956B-5F5F9A49004CQ34916914-255395D1-7344-43A1-839D-92ADB427E35AQ34960637-5C7A8351-9369-4621-AECB-E976FDC1041BQ34963649-9EDD283D-3800-490F-B267-E0F92B655681Q34990937-F4EE88DE-71DC-493A-92B4-4545613826A7Q35645278-CF879F5E-39E3-4458-B1A6-4A74C20C8EDEQ36427549-092D43E1-8D4E-4739-8314-ADB80E1CDAD4Q36771362-74B3887F-E254-4D33-810D-140FBF9DEE4AQ36913239-63938DD9-026A-4A26-BF93-F127F55F6FDCQ40715338-C721E760-1716-488B-809C-40E5506DAFC6Q40943819-25AFC8DD-5F81-4823-9E35-39C06B3D27F0Q41030114-FFA8D4B4-331A-45DD-820A-10EAD29A1743Q41253969-43AE5B3D-11C0-483B-B472-3624AAF44692Q41254966-22A7C043-F7FC-4882-BE54-C9AA3D9EE6D8Q41265083-EFC07664-CD48-4EAB-A30C-AE8BA514F2A5Q42204038-E4499A2A-77CE-44F1-A613-2202CFF4FEA6Q42417794-10919674-160B-4A6A-AB64-EAFBEABB371BQ46121740-08C8BA9A-31CB-4629-A543-32B85FDC8BA5
P2860
Comparative studies of antibacterial activity in vitro and absorption and excretion of lincomycin and clinimycin.
description
1968 nî lūn-bûn
@nan
1968年の論文
@ja
1968年学术文章
@wuu
1968年学术文章
@zh
1968年学术文章
@zh-cn
1968年学术文章
@zh-hans
1968年学术文章
@zh-my
1968年学术文章
@zh-sg
1968年學術文章
@yue
1968年學術文章
@zh-hant
name
Comparative studies of antibac ...... of lincomycin and clinimycin.
@en
Comparative studies of antibac ...... of lincomycin and clinimycin.
@nl
type
label
Comparative studies of antibac ...... of lincomycin and clinimycin.
@en
Comparative studies of antibac ...... of lincomycin and clinimycin.
@nl
prefLabel
Comparative studies of antibac ...... of lincomycin and clinimycin.
@en
Comparative studies of antibac ...... of lincomycin and clinimycin.
@nl
P2093
P1476
Comparative studies of antibac ...... of lincomycin and clinimycin.
@en
P2093
P304
P407
P577
1968-11-01T00:00:00Z